MyCondro for Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effects of a supplement called MyCondro™ on knee osteoarthritis. Researchers aim to determine if a daily dose of either 300 mg or 600 mg improves joint health, mobility, and reduces pain and stiffness. Individuals experiencing knee pain and difficulty moving for over six months might be suitable candidates. Participants must avoid certain foods and supplements during the study. The trial will track changes in knee health and daily activity over 12 weeks. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on knee osteoarthritis.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the FDA considers MyCondro™ safe for use in food, meaning it is safe when used as intended. A careful process ensures its safety and reliability. Previous studies indicate that MyCondro™ is well-tolerated, even in larger amounts. No major reports of side effects have emerged in people using MyCondro™ for joint health. This suggests the treatment is likely safe for those considering joining a trial.12345
Why are researchers excited about this trial?
Unlike the standard treatments for arthritis, which often include nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, MyCondro is a supplement that offers a different approach. Researchers are excited about MyCondro because it targets inflammation in a more natural way, potentially reducing side effects associated with traditional medications. This treatment is administered as a simple daily oral supplement, making it easy for patients to incorporate into their routines. With doses of 300 mg and 600 mg being tested, MyCondro could offer a flexible and promising alternative for managing arthritis symptoms.
What evidence suggests that MyCondro might be an effective treatment for knee osteoarthritis?
Research has shown that MyCondro™, a plant-based chondroitin sulfate supplement, may improve joint health in people with knee osteoarthritis. Studies have found that taking MyCondro™ for three months can significantly enhance knee function and reduce pain. Specifically, one study reported that participants who took the supplement experienced better knee movement control and lower levels of inflammation markers like C-reactive protein (CRP). Additionally, MyCondro™ absorbs better than animal-based chondroitin, potentially increasing its effectiveness. This trial will test different dosages of MyCondro™, with doses as low as 600 mg having shown impressive results in joint health in previous research.13467
Who Is on the Research Team?
Noah Craft, MD, PhD
Principal Investigator
People Science
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Shipping
Participants are randomly assigned to receive either a 300mg or 600mg dose of MyCondro™, and the product is shipped to them
Baseline
Participants complete baseline assessments and begin using the study product
Treatment
Participants receive the study product for 12 weeks, with data collection via app-based questionnaires, at-home blood sample kits, and wearable health tracking technology
Follow-up
Participants are monitored for safety and effectiveness after treatment, with final assessments and data collection
What Are the Treatments Tested in This Trial?
Interventions
- MyCondro
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Participants in this arm will receive a 600 mg daily dose of the supplement, administered as two capsules every morning after breakfast for a 12-week period
Participants in this arm will receive a 300 mg daily dose of the supplement, administered as two capsules every morning after breakfast for a 12-week period
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lesaffre International
Lead Sponsor
People Science
Collaborator
Citations
A Decentralized Clinical Study Evaluating the Effectiveness ...
This study evaluates the effect of two different doses of a consumer-grade product, MyCondro™, on individuals experiencing mobility issues ...
2.
ctv.veeva.com
ctv.veeva.com/study/a-decentralized-clinical-study-evaluating-the-effectiveness-of-two-different-doses-of-mycondro-on-pA Decentralized Clinical Study Evaluating the Effectiveness of Two ...
This study evaluates the effect of two different doses of a consumer-grade product, MyCondro™, on individuals experiencing mobility issues related to knee ...
3.
gnosisbylesaffre.com
gnosisbylesaffre.com/blog/high-intensity-exercise-and-joint-health-why-mycondro-matters/High-Intensity Exercise and Joint Health: Why MyCondro™ ...
A second randomized controlled trial (Rondanelli 2020) confirmed these findings, showing improved knee function and better control of ...
Effectiveness of Non-Animal Chondroitin Sulfate ... - PMC
This pilot study demonstrates the effectiveness of non-animal CS supplementation in overweight subjects with knee OA in improving knee function, pain and ...
5.
nutritionaloutlook.com
nutritionaloutlook.com/view/non-animal-chondroitin-sulfate-shows-efficacy-lower-dosage-says-recent-studyNon-animal chondroitin sulfate shows efficacy at a lower ...
Measures of inflammation also improved, with significant reductions in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in the ...
MyCondro™: The Chondroitin Sulfate from fermentatiion
Allergens and Food Safety. Safety and reliability define MyCondro™ at its foundation. Produced through a meticulously controlled manufacturing process, it ...
Efficacy and Safety of Two Chondroprotective Supplements in ...
Oral supplementation with either HA or Glc + CS demonstrated potential benefits for managing symptoms of mild-to-moderate knee OA.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.